
    
      -  Participants will begin this research study within 14 days of starting Bevacizumab,
           either as part of standard treatment or as part of another clinical trial.

        -  Participants will have an ultrasound test done at baseline, and after completion of
           their first and second cycles of therapy.

        -  Vital signs and blood tests will be performed a the start of the study, and after
           completion of the first and second cycles of therapy.
    
  